Callie brings 15 years of clinical research knowledge to I-ACT for Children with experience that includes project management, clinical monitoring, data management, site and vendor management, regulatory affairs, finance, and contracting. She joined I-ACT for Children from Rexahn Pharmaceuticals, an oncology-focused pharmaceutical biotech, where she was the associate director of clinical operations. Prior to that, she was a clinical research scientist/project manager with Vanda Pharmaceuticals. She has also held positions at Novartis and at a contract research organization focused on supporting clinical research projects sponsored by the National Institutes of Health. Callie earned her MSHS in Clinical Research Management from the George Washington University School of Medicine and Health Sciences and has maintained her CCRA certification from the Association of Clinical Research Professionals for more than 12 years.